Cargando…
Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
Chimeric antigen receptor (CAR)-modified T cells have demonstrated efficacy against B cell leukemias/lymphomas. However, redirecting CAR T cells to malignant T cells is more challenging due to product-specific cis- and trans-activation causing fratricide. Other challenges include the potential for p...
Autores principales: | Fleischer, Lauren C., Becker, Scott A., Ryan, Rebecca E., Fedanov, Andrew, Doering, Christopher B., Spencer, H. Trent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341062/ https://www.ncbi.nlm.nih.gov/pubmed/32671190 http://dx.doi.org/10.1016/j.omto.2020.06.003 |
Ejemplares similares
-
Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers
por: Becker, Scott A., et al.
Publicado: (2023) -
Genetic engineering of chimeric antigen receptors using lamprey derived variable lymphocyte receptors
por: Moot, Robert, et al.
Publicado: (2016) -
Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing
por: Branella, Gianna M., et al.
Publicado: (2021) -
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2019) -
Human αβ and γδ T Cells in Skin Immunity and Disease
por: Cruz, Michelle S., et al.
Publicado: (2018)